- Home
- ALGS vs CNVS Comparison
ALGS vs CNVS Comparison
Compare ALGS & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | CNVS |
|---|---|---|
| Founded | 2018 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.2M | 46.9M |
| IPO Year | 2020 | 2003 |
Fundamental Metrics
Financial Performance| Metric | ALGS | CNVS |
|---|---|---|
| Price | $11.14 | $2.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $60.00 | $9.00 |
| AVG Volume (30 Days) | 81.5K | ★ 146.2K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,646,000.00 | ★ $79,791,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $36.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 77.29 |
| 52 Week Low | $3.76 | $2.24 |
| 52 Week High | $46.80 | $7.39 |
Technical Indicators
Market Signals| Indicator | ALGS | CNVS |
|---|---|---|
| Relative Strength Index (RSI) | 60.44 | 33.53 |
| Support Level | $9.10 | $2.40 |
| Resistance Level | $13.69 | $2.51 |
| Average True Range (ATR) | 0.87 | 0.15 |
| MACD | 0.24 | 0.00 |
| Stochastic Oscillator | 50.23 | 5.95 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.